Hsp90 Inhibitors Identified from a Library of Novobiocin Analogues

Citations Over TimeTop 10% of 2005 papers

Abstract

Novobiocin is a C-terminal inhibitor of the Hsp90 protein folding machinery, which is responsible for the conformational maturation of numerous proteins involved in cancer growth and survival. Due to novobiocin's poor inhibitory activity ( approximately 700 muM), very little attention has been paid toward the development of novobiocin analogues for Hsp90 inhibition. In this study, a parallel library of 20 novobiocin derivatives was prepared and the biological activity of each evaluated by Western blot analysis of Hsp90 client proteins. A4 was found to be a potent inhibitor of Hsp90 as determined by its ability to cause the degradation of several Hsp90 client proteins in both breast and prostate cancer cell lines. In the presence of 1 muM A4, several Hsp90 client proteins were degraded, including AKT, Her2, Hif-1alpha, and the androgen receptor.

Related Papers

• → Characterization of a plasmid mutation affecting maintenance, transfer and elimination by novobiocin(1979)29 cited
• → Novobiocin; an inhibitor of the repair of UV-induced but not X-ray-induced damage in mammalian cells(1979)112 cited
• → Studies on the inhibition of repair of ultraviolet- and methyl methanesaHonate-indnced damage in the DNA of human fibrobhsts by novobiocin(1982)22 cited
• → Morphological changes associated with novobiocin resistance in Bacillus licheniformis(1977)9 cited
• → Effect of novobiocin on mycoplasma virus L2 replication(1984)3 cited